Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $118.6600 (-0.49%) ($118.6600 - $118.6600) on Tue. Jun. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.27% (three month average) | RSI | 42 | Latest Price | $118.6600(-0.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -1.635% in a week (0% probabilities). VIXM(-27%) VXX(-16%) UUP(-16%) IGOV(-6%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.635% (StdDev 3.27%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $109.73(-7.53%) | Resistance Level | $120.12 | 5 Day Moving Average | $115.93(2.35%) | 10 Day Moving Average | $116.23(2.09%) | 20 Day Moving Average | $120.12(-1.22%) | To recent high | -28.4% | To recent low | 5.1% | Market Cap | $1.907b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |